Posts In: NPPA

NPPA clarifies that the Hospitals / Nursing Homes / Clinics are allowed to add trade margins on orthopaedic knee implants as per the prescribed rates

September 6, 2019 OPS, Pharmaceuticals, states 0

In a recent notification dated 13th August 2019 the National Pharmaceutical Pricing Authority (“NPPA”) has once again extended the timeline of ceiling price fixed for orthopaedic knee implants...

Continue Reading

National Pharmaceutical Pricing Authority (“NPPA”) notifies fixation of ceiling prices for Povidone Iodine; effective 21st December, 2018

January 2, 2019 OPS, Pharmaceuticals, states 0

The National Pharmaceutical Pricing Authority (“NPPA”) has revised the ceiling prices (exclusive of goods and services tax applicable, if any) of Providone Iodine by an...

Continue Reading

NPPA extends the period of ceiling prices of Orthopaedic knee implants till 15th August, 2019

August 17, 2018 EHS, Pharmaceuticals, states 0

In a recent notification dated 16th August, 2018, the National Pharmaceutical Pricing Authority (“NPPA”) has extended the timeline of ceiling price fixed for orthopaedic knee...

Continue Reading

NPPA extends date of submission of price data of 19 medical devices to 15th March, 2018

March 4, 2018 OPS, Pharmaceuticals, states 0

In a recent office memorandum (“O.M.”) dated 27th February, 2018 the National Pharmaceutical Pricing Authority (“NPPA”) has extended the date of submission of price data in the attached format...

Continue Reading

NPPA issues an analysis showing that private hospitals are hugely overcharging patients

February 21, 2018 CORP, Industries, states 0

In an Office Memorandum dated February 20, 2018, the National Pharmaceutical Pricing Authority (“NPPA”) has published an analysis, after receiving complaints of overpricing and inflated bills from...

Continue Reading

NPPA revises ceiling price of coronary stents for the year 2018

February 14, 2018 OPS, Pharmaceuticals, states 2

Further to the update shared in the trail mail, the National Pharmaceutical Pricing Authority (“NPPA”) has revised the ceiling prices of coronary stents vide notification...

Continue Reading

NPPA relaxes the requirement of linking price approval of new drugs to Integrated Pharmaceutical Database Management System

December 26, 2017 Healthcare, OPS, Pharmaceuticals, states 0

In a recent Office Memorandum dated December 19, 2017 the National Pharmaceutical Pricing Authority (“NPPA”) has announced that price approval of new drugs will not...

Continue Reading

NPPA directs pharma companies to furnish PTR and MAT values for the formulations mentioned in the NELM,2015

December 12, 2017 OPS, Pharmaceuticals, states 0

The National Pharmaceutical Pricing Authority (“NPPA”), vide office memorandum dated 7th December, 2017, has directed all concerned manufacturing / marketing companies to furnish the Price To...

Continue Reading